tiprankstipranks
Trending News
More News >
Novartis Ag (NVS)
NYSE:NVS
US Market

Novartis (NVS) Ratios

Compare
3,679 Followers

Novartis Ratios

NVS's free cash flow for Q4 2024 was $0.75. For the 2024 fiscal year, NVS's free cash flow was decreased by $ and operating cash flow was $0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.04 1.16 1.29 1.51 0.90
Quick Ratio
0.84 0.93 1.04 1.29 0.68
Cash Ratio
0.40 0.51 0.26 0.41 0.29
Solvency Ratio
0.31 0.43 0.24 0.46 0.17
Operating Cash Flow Ratio
0.61 0.55 0.50 0.50 0.41
Short-Term Operating Cash Flow Coverage
2.18 2.38 2.40 2.39 1.39
Net Current Asset Value
$ -28.42B$ -22.71B$ -21.12B$ -18.25B$ -45.72B
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.26 0.24 0.24 0.29
Debt-to-Equity Ratio
0.71 0.56 0.47 0.46 0.67
Debt-to-Capital Ratio
0.42 0.36 0.32 0.31 0.40
Long-Term Debt-to-Capital Ratio
0.33 0.28 0.25 0.25 0.32
Financial Leverage Ratio
2.32 2.14 1.98 1.95 2.33
Debt Service Coverage Ratio
2.09 2.56 1.97 2.11 1.26
Interest Coverage Ratio
14.46 11.43 10.99 33.23 11.68
Debt to Market Cap
0.15 0.12 0.14 0.16 0.18
Interest Debt Per Share
16.14 13.10 13.20 14.23 17.09
Net Debt to EBITDA
0.96 0.71 1.39 1.09 1.86
Profitability Margins
Gross Profit Margin
75.20%73.27%70.12%69.99%69.70%
EBIT Margin
28.32%21.38%15.39%22.13%20.35%
EBITDA Margin
40.05%39.19%28.41%32.40%30.53%
Operating Profit Margin
28.12%20.94%17.75%50.96%20.35%
Pretax Profit Margin
26.37%19.55%16.15%49.43%19.80%
Net Profit Margin
23.09%31.83%13.42%45.43%16.18%
Continuous Operations Profit Margin
23.08%18.37%11.67%16.41%14.83%
Net Income Per EBT
87.54%162.78%83.08%91.90%81.72%
EBT Per EBIT
93.78%93.39%91.02%96.99%97.30%
Return on Assets (ROA)
11.68%14.86%5.92%18.23%6.11%
Return on Equity (ROE)
27.11%31.82%11.72%35.51%14.26%
Return on Capital Employed (ROCE)
19.77%13.28%10.36%26.53%10.25%
Return on Invested Capital (ROIC)
15.55%11.49%8.05%22.90%7.61%
Return on Tangible Assets
23.61%29.86%12.31%35.32%12.37%
Earnings Yield
6.14%7.08%3.71%12.94%3.97%
Efficiency Ratios
Receivables Turnover
5.42 5.74 5.80 5.99 5.50
Payables Turnover
2.81 2.53 3.01 2.86 2.80
Inventory Turnover
2.24 2.11 2.16 2.38 2.12
Fixed Asset Turnover
4.76 4.27 4.25 4.03 3.58
Asset Turnover
0.51 0.47 0.44 0.40 0.38
Working Capital Turnover Ratio
20.27 7.56 4.36 8.72 -46.50
Cash Conversion Cycle
100.07 92.44 110.75 86.54 108.08
Days of Sales Outstanding
67.32 63.55 62.93 60.94 66.37
Days of Inventory Outstanding
162.85 173.05 169.11 153.34 172.13
Days of Payables Outstanding
130.10 144.16 121.29 127.74 130.42
Operating Cycle
230.17 236.60 232.04 214.28 238.50
Cash Flow Ratios
Operating Cash Flow Per Share
8.81 6.96 6.53 6.72 5.99
Free Cash Flow Per Share
6.90 5.64 5.30 5.40 4.86
CapEx Per Share
1.91 1.33 1.22 1.32 1.14
Free Cash Flow to Operating Cash Flow
0.78 0.81 0.81 0.80 0.81
Dividend Paid and CapEx Coverage Ratio
1.54 1.44 1.40 1.46 1.43
Capital Expenditure Coverage Ratio
4.62 5.25 5.33 5.07 5.28
Operating Cash Flow Coverage Ratio
0.56 0.55 0.51 0.48 0.36
Operating Cash Flow to Sales Ratio
0.34 0.31 0.27 0.29 0.27
Free Cash Flow Yield
7.10%5.58%6.18%6.52%5.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.29 14.12 26.92 7.73 25.21
Price-to-Sales (P/S) Ratio
3.76 4.49 3.61 3.51 4.08
Price-to-Book (P/B) Ratio
4.42 4.49 3.16 2.74 3.60
Price-to-Free Cash Flow (P/FCF) Ratio
14.09 17.91 16.19 15.34 18.39
Price-to-Operating Cash Flow Ratio
11.04 14.50 13.15 12.32 14.91
Price-to-Earnings Growth (PEG) Ratio
-0.99 0.11 -0.38 0.04 1.87
Price-to-Fair Value
4.42 4.49 3.16 2.74 3.60
Enterprise Value Multiple
10.35 12.18 14.10 11.93 15.22
EV to EBITDA
10.35 12.18 14.10 11.93 15.22
EV to Sales
4.14 4.77 4.01 3.86 4.65
EV to Free Cash Flow
15.53 19.02 17.96 16.88 20.96
EV to Operating Cash Flow
12.17 15.40 14.59 13.56 16.99
Tangible Book Value Per Share
-3.77 -1.67 -0.70 1.80 -4.45
Shareholders’ Equity Per Share
22.03 22.47 27.21 30.17 24.86
Tax and Other Ratios
Effective Tax Rate
0.12 0.06 0.17 0.08 0.18
Revenue Per Share
25.87 22.47 23.76 23.58 21.91
Net Income Per Share
5.97 7.15 3.19 10.71 3.54
Tax Burden
0.88 1.63 0.83 0.92 0.82
Interest Burden
0.93 0.91 1.05 2.23 0.97
Research & Development to Revenue
0.19 0.24 0.19 0.18 0.18
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.01
Income Quality
1.48 1.69 2.05 0.63 1.69
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis